Reported a net loss of $113,988 for the three months ended March 31, 2026. Maintained $670,328 in cash and $3,006,138 in the trust account as of March 31, 2026. Entered into a merger agreement with Bioserica International Limited on May 23, 2025, with an aggregate consideration of $217,860,000. Extended the deadline to complete a business combination to November 12, 2026. Completed a share exchange on January 16, 2026, where the sponsor exchanged 1,499,900 Class B shares for Class A shares.